Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you're taking Mounjaro and want to keep lifting, the short answer is that resistance training and tirzepatide work well together — and there are good reasons to make weight lifting a deliberate part of your treatment. Mounjaro is a prescription-only medicine requiring clinical assessment; the decision about exercise is yours, but the evidence points clearly in one direction. Rapid weight loss from any treatment carries a risk of muscle loss alongside fat loss, and structured resistance training is the most reliable way to counter that. What follows covers the specific decisions worth thinking about: how to fuel your lifts when appetite is reduced, how to protect muscle mass, and when to flag anything to your prescriber.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Weight loss (from any intervention, not just medication) draws on fat stores and, to a degree that varies by individual, lean muscle tissue. The faster the loss, the higher the proportion of muscle that can go with it. Tirzepatide produces relatively rapid reductions in body weight, particularly in the early months, which makes protecting muscle mass an active task rather than a passive one.
Resistance training sends a direct signal to muscle fibres to maintain and, over time, build. That signal competes with the catabolic pressure that comes from a caloric deficit. Studies in populations undergoing medically supervised weight loss consistently show that people who include structured resistance work preserve significantly more lean mass than those who focus on cardiovascular exercise alone.
This is especially relevant for anyone tracking their results. The scales may show a given number, but whether that loss is predominantly fat or a mixture of fat and muscle is shaped substantially by whether you're lifting. If you'd like a broader picture of how Mounjaro drives weight change, the overview of Mounjaro and weight covers the mechanisms in more detail.
The practical upshot: treating resistance training as optional once you start tirzepatide is a decision that tends to cost people later. Treat it as part of the plan from the beginning.
One of the things our prescribers hear regularly from people a few weeks into treatment is that eating enough to support training feels genuinely difficult. Appetite reduction is the intended effect of tirzepatide; the challenge is that the body still needs adequate protein and overall calories to recover from resistance exercise and preserve the muscle you're working to keep.
Protein is the priority. Most sports nutrition guidance for people in a calorie deficit suggests aiming for 1.6–2.2g of protein per kilogram of body weight per day. That figure doesn't change because you're on Mounjaro; if anything, the case for hitting it consistently becomes stronger. Spreading protein across meals (rather than concentrating it at one sitting) tends to be more manageable when total food volume is lower.
Practical approaches that people on treatment often find useful: protein-dense foods that are small in volume (Greek yoghurt, eggs, tinned fish, cottage cheese), protein shakes as a practical gap-filler rather than a meal replacement, and eating your largest protein serving shortly after training when appetite may be slightly less suppressed than usual. Hydration deserves equal attention, gastrointestinal side effects can affect fluid balance, and dehydration compounds both nausea and muscle recovery.
Timing matters for another reason: if you train first thing in the morning, you're already in a fasted state. That can work for some people, but if it leaves you feeling worse than usual, shifting training to later in the day (after even a small protein-containing meal) is worth trying. A question we get occasionally around this: does Mounjaro change how food tastes? There's some evidence it can; the page on Mounjaro and taste perception covers what's known.
Gastrointestinal effects (nausea, loose stools, fatigue, reflux) are the most commonly reported side effects of tirzepatide, and they tend to cluster in the days immediately after an injection or following a dose increase. The tirzepatide overview has a full picture of the side-effect profile, and the NHS medicines page for tirzepatide provides detailed patient-level information on what to watch for.
For practical planning around training: some people find the 24–48 hours after their weekly injection are the worst for GI discomfort, and scheduling demanding sessions (heavy compound lifts, high-volume leg days) on days three to six of the week can reduce clashes. That timing also maps reasonably well onto weekly rhythms people already observe: many patients on Mounjaro inject on a fixed day, so it's possible to plan around it. Payday-week gym motivation, a Monday morning injection, a long weekend trip, once you know your pattern, you can build a schedule that avoids the rough days for your hardest sessions.
If fatigue or nausea is significant enough to affect training quality consistently, rather than transiently, that's worth raising at your next clinical review rather than simply pushing through. The NHS guidance on tirzepatide side effects outlines which symptoms warrant prompt attention and which are expected to settle.
The evidence for tirzepatide's effectiveness in weight management is substantial. In SURMOUNT-1, a large clinical trial involving thousands of adults with obesity, participants at the highest dose saw average body-weight reductions of around 20–21% over 72 weeks. Results of that scale inevitably prompt questions about what's actually being lost. Monitoring your progress beyond the scales (tracking strength in key lifts, body measurements, or how clothes fit) gives a richer picture than weight alone.
It's also worth noting that weight loss slows over time, and some people find motivation for training fluctuates alongside it. The detail on the weight loss pattern during treatment may help set realistic expectations for what different phases look like.
If you're considering stopping treatment at some point, the interaction between maintained muscle mass and long-term weight management is another reason to have built a solid resistance training habit beforehand, muscle tissue is metabolically active and helps sustain results. The page on stopping and restarting Mounjaro covers that transition in full.
For anyone exploring cost as part of their decision about private treatment, the Mounjaro cost overview explains what to expect and what to look for in a legitimate provider. And if you're ready to talk to a prescriber about whether treatment is right for you, start your free consultation, a real clinician reviews it the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.